Affiliations 

  • 1 IBD Centre, Department of Medical Gastroenterology, Asian Institute of Gastroenterology, Mindspace Road, Gachibowli, Hyderabad, 500 032, India. dr_rupa_banerjee@hotmail.com
  • 2 IBD Centre, Department of Medical Gastroenterology, Asian Institute of Gastroenterology, Mindspace Road, Gachibowli, Hyderabad, 500 032, India
  • 3 University of Malaya Medical Centre, Kuala Lumpur, Malaysia
  • 4 Sheikh Russel National GastroLiver Institute and Hospital, Dhaka, Bangladesh
  • 5 Mahidol University, Bangkok, Thailand
  • 6 National Medical Centre, Karachi, Pakistan
  • 7 Apollo Institute of Gastrosciences and Liver, Apollo Multispeciality Hospitals, Kolkata, 700 054, India
  • 8 Yangon General Hospital University of Medicine, Yangon, Myanmar
  • 9 Nidan Hospital, Kathmandu, Nepal
  • 10 Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 11 Yashoda Hospital, Hyderabad, India
Indian J Gastroenterol, 2024 Dec;43(6):1156-1167.
PMID: 39023742 DOI: 10.1007/s12664-024-01617-y

Abstract

BACKGROUND: Mental health is an overlooked aspect of inflammatory bowel disease (IBD) patient care with limited data from the developing world. The primary caregiver burden is expected to be high, but has not been evaluated.

METHODS: We conducted a questionnaire-based survey of consecutive out-patients with no diagnosed mental health illness (n = 289) and their primary caregivers (n = 247) from 10 centers across eight countries (Bangladesh, India, Iran, Malaysia, Myanmar, Nepal, Pakistan, Thailand) of IBD-Emerging Nations' Consortium (ENC). Patients were assessed for anxiety (PHQ-9), depression (GAD-7), quality of life (SIBDQ, IBDCOPE) and medication adherence (MMAS-8). Caregiver burden was assessed by Zarit-Burden Interview (ZBI), Ferrans and Power Quality of Life (QOL) scores and coping strategies (BRIEF-COPE). Multivariate logistic regression and correlation analyses were performed to identify risk factors and the impact on QOL in patients and caregivers.

RESULTS: Moderate to severe depression and anxiety were noted in 33% (severe 3.5%) and 24% (severe 3.8%) patients, respectively. The risk factor for depression was active disease (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.